Home » About CHI » Leadership » Rick E. Winningham
Rick E. Winningham
Chief Executive Officer
Theravance
Winningham joined Theravance as chief executive officer and member of the board of directors in October 2001, and was appointed chairman of the board in April 2010. Since assuming the role of CEO, Theravance has successfully transitioned from a private research-based small molecule discovery company to a public company with a robust portfolio of product candidates, both in clinical development and on the market. Prior to joining Theravance, Winningham held various management positions with Bristol-Myers Squibb and its predecessor, Bristol-Myers, since 1986. During his tenure with BMS, he was associated with the development and commercialization of several major pharmaceutical products, such as Taxol, Paraplatin, Zerit, Videx, Reyataz, and Abilify. He holds a bachelor’s degree from Southern Illinois University and a master’s of business administration from Texas Christian University. He serves the board of Jazz Pharmaceuticals Inc. and is a member of the external advisory board for the College of Business and Administration and Business Hall of Fame at Southern Illinois University.